Ilse Smolders Selected Research

Vesicular Neurotransmitter Transport Proteins

8/2013

Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ilse Smolders Research Topics

Disease

41	Seizures (Absence Seizure) 01/2022 - 08/2002
25	Epilepsy (Aura) 12/2021 - 08/2002
8	Parkinson Disease (Parkinson's Disease) 03/2017 - 10/2008
7	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021 - 06/2010
6	Temporal Lobe Epilepsy 01/2021 - 05/2011
5	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 09/2008
3	Cognitive Dysfunction 01/2021 - 01/2008
3	Drug Resistant Epilepsy 01/2015 - 01/2007
3	Memory Disorders (Memory Loss) 04/2011 - 07/2009
2	Disease Progression 01/2021 - 01/2015
2	Inflammation (Inflammations) 01/2018 - 02/2006
2	Nervous System Diseases (Neurological Disorders) 01/2015 - 03/2013
1	Wounds and Injuries (Trauma) 03/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 03/2021
1	Body Weight (Weight, Body) 01/2021
1	Dementia (Dementias) 01/2021
1	Oculodentodigital Dysplasia 11/2020
1	Obesity 01/2020
1	AIDS-Related Complex (ARC) 01/2020
1	Neuroinflammatory Diseases 01/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2018
1	Anhedonia 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2017
1	Treatment-Resistant Depressive Disorder 01/2017
1	Parkinsonian Disorders (Parkinsonism) 01/2017

Drug/Important Bio-Agent (IBA)

23	Pilocarpine (Ocusert)FDA LinkGeneric 01/2022 - 08/2002
23	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 03/2004
15	Glutamic Acid (Glutamate)FDA Link 11/2020 - 08/2002
10	LigandsIBA 12/2021 - 03/2004
9	Dopamine (Intropin)FDA LinkGeneric 03/2017 - 12/2004
7	Serotonin (5 Hydroxytryptamine)IBA 05/2015 - 05/2004
5	GhrelinIBA 12/2021 - 04/2012
5	Proteins (Proteins, Gene)FDA Link 11/2020 - 08/2005
5	Pentylenetetrazole (Metrazol)IBA 01/2019 - 07/2009
5	gamma-Aminobutyric Acid (GABA)IBA 04/2015 - 08/2002
4	Kainic Acid (Kainate)IBA 03/2019 - 06/2010
4	Cystine (L-Cystine)IBA 01/2019 - 10/2008
4	Neurotransmitter Agents (Neurotransmitter)IBA 05/2015 - 01/2008
3	Pharmaceutical PreparationsIBA 01/2022 - 09/2008
3	Ghrelin ReceptorsIBA 12/2021 - 06/2015
3	AntiportersIBA 01/2019 - 10/2008
3	Peptides (Polypeptides)IBA 01/2018 - 01/2008
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 08/2015 - 08/2006
3	AngiotensinsIBA 05/2015 - 01/2008
3	Citalopram FDA LinkGeneric 05/2012 - 12/2004
3	des-Asp(1)-des-Arg(2)-Ile(5)- angiotensin IIIBA 03/2010 - 08/2006
2	Glycogen Synthase Kinase 3IBA 01/2022 - 01/2019
2	Protein Isoforms (Isoforms)IBA 01/2022 - 02/2006
2	MelatoninIBA 01/2021 - 01/2021
2	macimorelinIBA 01/2021 - 05/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2011
2	Connexin 43 (Connexin43)IBA 11/2020 - 01/2018
2	CitrullineIBA 09/2020 - 05/2005
2	Serine (L-Serine)FDA Link 01/2018 - 09/2015
2	NAD (NADH)IBA 01/2017 - 05/2015
2	lactacystinIBA 01/2017 - 01/2015
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2015 - 05/2011
2	EnzymesIBA 04/2015 - 02/2006
2	Diazepam (Valium)FDA LinkGeneric 04/2015 - 06/2010
2	Vesicular Glutamate Transport ProteinsIBA 03/2015 - 01/2011
2	Glutathione (Reduced Glutathione)IBA 06/2014 - 04/2011
2	NeuropeptidesIBA 07/2012 - 04/2012
2	ConvulsantsIBA 05/2012 - 08/2006
2	Reboxetine (Vestra)IBA 05/2012 - 11/2011
2	Antidepressive Agents (Antidepressants)IBA 05/2012 - 11/2011
2	3,4-dihydroxyphenylglycolIBA 01/2008 - 03/2004
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2008 - 03/2004
2	5-HT1A Serotonin ReceptorIBA 12/2005 - 05/2004
2	Amino Acids FDA Link 05/2005 - 03/2004
1	TCS2002IBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	disodium salt olean-11,13(18)-diene-3,30-diol dihemiphthalateIBA 11/2020
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 09/2020
1	Histidine (L-Histidine)FDA Link 09/2020
1	Phenylalanine (L-Phenylalanine)FDA Link 09/2020
1	Lysine (L-Lysine)FDA Link 09/2020
1	Methionine (L-Methionine)FDA Link 09/2020
1	3-methyladenineIBA 09/2020
1	neuromedin U 8IBA 01/2020
1	YIL 781IBA 05/2019
1	Plant ExtractsIBA 01/2019
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2019
1	6-bromoindirubin-3'-acetoximeIBA 01/2019
1	indirubinIBA 01/2019
1	LipopolysaccharidesIBA 01/2018
1	TAT-Gap19 peptideIBA 01/2018
1	EndotoxinsIBA 01/2018
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2018
1	CytokinesIBA 01/2018
1	N- ((5- (3- (1- benzylpiperidin- 4- yl)propoxy)- 1- methyl- 1H- indol- 2- yl)methyl)- N- methylprop- 2- yn- 1- amineIBA 03/2017
1	Therapeutic UsesIBA 01/2017
1	Zonisamide (Zonegran)FDA LinkGeneric 01/2017
1	Neuroprotective AgentsIBA 01/2016
1	Oxidopamine (6 Hydroxydopamine)IBA 09/2015

Therapy/Procedure

7	Therapeutics 01/2020 - 08/2002
2	Vagus Nerve Stimulation 01/2015 - 05/2011
1	Transcranial Direct Current Stimulation 03/2021
1	Electrodes (Electrode) 01/2019
1	Injections 01/2018
1	Transcranial Magnetic Stimulation 01/2017